Path of Science: International Electronic Scientific Journal

Antimicrobial resistance (AMR) represents a growing public health challenge in Nigeria. The pervasive misuse of antibiotics, insufficient regulatory frameworks, and inadequate surveillance systems exacerbate this issue. The existing methods for antibiotic monitoring are fragmented and inefficient, hindering the ability to detect real-time resistance patterns. This review delves into the role of digital surveillance technologies in combating AMR, taking advantage of electronic medical records (EMRs), mobile health (mHealth) applications, AI-powered analytics, and cloud-based databases to enhance data collection, prescription tracking, and policy interventions. Research conducted in low- and middle-income countries (LMICs), including India and Kenya, demonstrates digital tools' efficacy in addressing antimicrobial resistance (AMR). Despite these advantages, Nigeria continues to face significant challenges related to data privacy, infrastructure limitations, financial sustainability, and a digital divide between urban and rural regions. Addressing these limitations requires implementing strategic investments in health technology, establishing robust regulatory frameworks, and fostering multi-sectoral collaboration among government agencies, private sector stakeholders, healthcare institutions, and research organisations. In this review, we strongly advocate for an approach that integrates a data-driven antimicrobial resistance (AMR) surveillance system, facilitating real-time monitoring and policy-driven strategies. Nigeria can enhance antibiotic stewardship, mitigate resistance, and protect public health by evolving into a robust digital health ecosystem.

1. Iheanacho, C. O., & Eze, U. I. H. (2022). Antimicrobial resistance in Nigeria: challenges and charting the way forward. European Journal of Hospital Pharmacy, 29(2), 119. doi: 10.1136/ejhpharm-2021-002762

2. Akande-Sholabi, W., & Oyesiji, E. (2023). Antimicrobial stewardship: knowledge, perceptions, and factors associated with antibiotic misuse among consumers visiting the community pharmacies in a Nigeria Southwestern State. Journal of Pharmaceutical Policy and Practice, 16(1). doi: 10.1186/s40545-023-00629-x

3. Sutton, K. F., & Ashley, L. W. (2024). Antimicrobial resistance in the United States: Origins and future directions. Epidemiology and Infection, 152. doi: 10.1017/s0950268824000244

4. Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Da Silva, D. D. (2024). An overview of the recent advances in antimicrobial resistance. Microorganisms, 12(9), 1920. doi: 10.3390/microorganisms12091920

5. Cooper, G. M. (2000). The Cell: A Molecular Approach (2nd ed.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK9963/

6. Rabaan, A. A., Alhumaid, S., Mutair, A. A., Garout, M., Abulhamayel, Y., Halwani, M. A., Alestad, J. H., Bshabshe, A. A., Sulaiman, T., AlFonaisan, M. K., Almusawi, T., Albayat, H., Alsaeed, M., Alfaresi, M., Alotaibi, S., Alhashem, Y. N., Temsah, M., Ali, U., & Ahmed, N. (2022). Application of artificial intelligence in combating high antimicrobial resistance rates. Antibiotics, 11(6), 784. doi: 10.3390/antibiotics11060784

7. Pillay, S., Calderón-Franco, D., Urhan, A., & Abeel, T. (2022). Metagenomic-based surveillance systems for antibiotic resistance in non-clinical settings. Frontiers in Microbiology, 13. doi: 10.3389/fmicb.2022.1066995

8. Chukwu, E. E., Oladele, D. A., Awoderu, O. B., Afocha, E. E., Lawal, R. G., Abdus-Salam, I., Ogunsola, F. T., & Audu, R. A. (2020). A national survey of public awareness of antimicrobial resistance in Nigeria. Antimicrobial Resistance and Infection Control, 9(1). doi: 10.1186/s13756-020-00739-0

9. Ogunleye, O. O., Oyawole, M. R., Odunuga, P. T., Kalejaye, F., Yinka-Ogunleye, A. F., Olalekan, A., Ogundele, S. O., Ebruke, B. E., Richard, A. K., Paramadhas, B. D. A., Kurdi, A., Sneddon, J., Seaton, A., & Godman, B. (2021). A multicentre point prevalence study of antibiotics utilisation in hospitalised patients in Nigeria's urban secondary and tertiary healthcare facilities: findings and implications. Expert Review of Anti-infective Therapy, 20(2), 297–306. doi: 10.1080/14787210.2021.1941870

10. Pokharel, S., Adhikari, B., Johnson, T., & Cheah, P. Y. (2024). Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low- income and middle-income countries. BMJ Global Health, 9(4), e012874. doi: 10.1136/bmjgh-2023-012874

11. Ajekiigbe, V. O., Ogieuhi, I. J., Odeniyi, T. A., Ogunleke, P. O., Olatunde, J. T., Babalola, A. V., Omoleke, A. A., Omitade, T. F., Olakanmi, D. E., Akingbola, A., & Anthony, C. S. (2025). Understanding Nigeria's antibiotic resistance crisis among neonates and its future implications. Deleted Journal, 22(1). doi: 10.1186/s12982-025-00422-y

12. Abubakar, I., Dalglish, S. L., Angell, B., Sanuade, O., Abimbola, S., Adamu, A. L., Adetifa, I. M. O., Colbourn, T., Ogunlesi, A. O., Onwujekwe, O., Owoaje, E. T., Okeke, I. N., Adeyemo, A., Aliyu, G., Aliyu, M. H., Aliyu, S. H., Ameh, E. A., Archibong, B., Ezeh, A., & Zanna, F. H. (2022). The Lancet Nigeria Commission: investing in health and the nation's future. The Lancet, 399(10330), 1155–1200. doi: 10.1016/s0140-6736(21)02488-0

13. Nwobodo, D. C., Ugwu, M. C., Anie, C. O., Al‐Ouqaili, M. T. S., Ikem, J. C., Chigozie, U. V., & Saki, M. (2022). Antibiotic resistance: The challenges and emerging strategies for tackling a global menace. Journal of Clinical Laboratory Analysis, 36(9). doi: 10.1002/jcla.24655

14. Ogunleye, O. O., Fadare, J. O., Yinka-Ogunleye, A. F., Paramadhas, B. D. A., & Godman, B. (2018). Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital. Hospital Practice, 47(1), 53–58. doi: 10.1080/21548331.2018.1475997

15. Sartelli, M., Barie, P. S., Coccolini, F., Abbas, M., Abbo, L. M., Abdukhalilova, G. K., Abraham, Y., Abubakar, S., Abu-Zidan, F. M., Adebisi, Y. A., Adamou, H., Afandiyeva, G., Agastra, E., Alfouzan, W. A., Al-Hasan, M. N., Ali, S., Ali, S. M., Allaw, F., Allwell-Brown, G., & Catena, F. (2023). Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. World Journal of Emergency Surgery, 18(1). doi: 10.1186/s13017-023-00518-3

16. Lim, C., Ashley, E. A., Hamers, R. L., Turner, P., Kesteman, T., Akech, S., Corso, A., Mayxay, M., Okeke, I. N., Limmathurotsakul, D., & Van Doorn, H. R. (2021). Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries. Clinical Microbiology and Infection, 27(10), 1391–1399. doi: 10.1016/j.cmi.2021.05.037

17. Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023). Origin of Antibiotics, antibiotic resistance, and their Impacts on Drug Development: A Narrative review. Pharmaceuticals, 16(11), 1615. doi: 10.3390/ph16111615

18. Tornimbene, B., Eremin, S., Abednego, R., Abualas, E. O., Boutiba, I., Egwuenu, A., Fuller, W., Gahimbare, L., Githii, S., Kasambara, W., Lukwesa-Musyani, C., Miamina, F. A., Mtapuri-Zinyowera, S., Najjuka, G., Perovic, O., Zayed, B., Ahmed, Y. A., Ismail, M. T., & Da Silva, C. L. P. (2022). Global Antimicrobial Resistance and Use Surveillance System in Africa: Early implementation 2017–2019. African Journal of Laboratory Medicine, 11(1). doi: 10.4102/ajlm.v11i1.1594

19. Willemsen, A., Reid, S., & Assefa, Y. (2022). A review of national action plans on antimicrobial resistance: strengths and weaknesses. Antimicrobial Resistance and Infection Control, 11(1). doi: 10.1186/s13756-022-01130-x

20. Oleribe, O. E., Momoh, J., Uzochukwu, B. S., Mbofana, F., Adebiyi, A., Barbera, T., Williams, R., & Robinson, S. D. T. (2019). Identifying Key Challenges Facing Healthcare Systems In Africa And Potential Solutions. International Journal of General Medicine, 12, 395–403. doi: 10.2147/ijgm.s223882

21. Kanan, M., Ramadan, M., Haif, H., Abdullah, B., Mubarak, J., Ahmad, W., Mari, S., Hassan, S., Eid, R., Hasan, M., Qahl, M., Assiri, A., Sultan, M., Alrumaih, F., & Alenzi, A. (2023). RETRACTED: Empowering Low- and Middle-Income Countries to combat AMR by minimal use of antibiotics: A Way forward. Antibiotics, 12(10), 1504. doi: 10.3390/antibiotics12101504

22. Albahar, F., Abu-Farha, R. K., Alshogran, O. Y., Alhamad, H., Curtis, C. E., & Marriott, J. F. (2023). Healthcare Professionals' Perceptions, Barriers, and Facilitators Towards Adopting Computerised Clinical Decision Support Systems in Antimicrobial Stewardship in Jordanian Hospitals. Healthcare, 11(6), 836. doi: 10.3390/healthcare11060836

23. Lawal, O. P., Ahmed, N. K., Ilesanmi, T. A., Anthony, G. I., Nwosu, S. N., Ogungbemiro, F. O., Olaide, Z., Adeniyi, M. M., Okoye, U. L., Olufunmilayo, A. M., Christopher, A. A., & Oseghale, I. D. (2024). The impact of antimicrobial resistance on cancer treatment: A systematic review of current evidence and future directions. Asian Journal of Research in Medical and Pharmaceutical Sciences, 13(4), 9–27. doi: 10.9734/ajrimps/2024/v13i4270

24. Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. a. A. (2023). Antimicrobial resistance: a growing serious threat for global public health. Healthcare, 11(13), 1946. doi: 10.3390/healthcare11131946

25. Robillard, D. W., Sundermann, A. J., Raux, B. R., & Prinzi, A. M. (2024). Navigating the network: a narrative overview of AMR surveillance and data flow in the United States. Antimicrobial Stewardship & Healthcare Epidemiology, 4(1). doi: 10.1017/ash.2024.64

26. Rezel-Potts, E., & Gulliford, M. (2022). Electronic Health Records and Antimicrobial Stewardship Research: a Narrative Review. Current Epidemiology Reports, 10(3), 132–141. doi: 10.1007/s40471-021-00278-1

27. Walia, K., Madhumathi, J., Veeraraghavan, B., Chakrabarti, A., Kapil, A., Ray, P., Singh, H., Sistla, S., & Ohri, V. C. (2019). Establishing antimicrobial resistance surveillance & Research network in India: Journey so far. The Indian Journal of Medical Research, 149(2), 164. doi: 10.4103/ijmr.ijmr_226_18

28. Chuchu, V. M., Njung’e, J., Muasa, B., Gathira, M., Olela, G., Bubi, K. S., Ashaba, J., Githii, S., Ndanyi, R., Tanui, E., Irungu, J. I., Azegele, A., Kadam, R., & Ferreyra, C. (2024). Progress was made in digitalising antimicrobial resistance surveillance using a One Health approach in Kenya. Frontiers in Public Health, 12. Doi 10.3389/fpubh.2024.1411962

29. Sumpradit, N., Wongkongkathep, S., Malathum, K., Janejai, N., Paveenkittiporn, W., Yingyong, T., Chuxnum, T., Vijitleela, A., Boonyarit, P., Akaleephan, C., Manosuthi, W., Thienthong, V., Srinha, J., Wongsrichai, S., Laoprasert, T., Athipunyakom, P., Kriengchaiyaprug, N., Intarukdach, K., Numsawad, S., & Kiatying-Angsulee, N. (2021). Thailand's national strategic plan on antimicrobial resistance: progress and challenges. Bulletin of the World Health Organisation, 99(09), 661–673. doi: 10.2471/blt.20.280644

30. Chika, E. U., BPharm, D. U. P., BPharm, A. K., BPharm, G. E., BPharm, N. T. O., Chidozie, C., & Madubugwu, R. (2024). Digital Healthcare Tools in Nigeria: Strengthening Public Health and Pandemic Preparedness - Insights from the COVID-19 Crisis. Telehealth and Medicine Today, 9(1). doi: 10.30953/thmt.v9.445

31. Otaigbe, I. I. (2023). Achieving universal health coverage in low- and middle-income countries through digital antimicrobial stewardship. Frontiers in Digital Health, 5. doi: 10.3389/fdgth.2023.1298861

32. Rezel-Potts, E., & Gulliford, M. (2022b). Electronic Health Records and Antimicrobial Stewardship Research: a Narrative Review. Current Epidemiology Reports, 10(3), 132–141. doi: 10.1007/s40471-021-00278-1

33. Kamere, N., Garwe, S. T., Akinwotu, O. O., Tuck, C., Krockow, E. M., Yadav, S., Olawale, A. G., Diyaolu, A. H., Munkombwe, D., Muringu, E., Muro, E. P., Kaminyoghe, F., Ayotunde, H. T., Omoniyei, L., Lawal, M. O., Barlatt, S. H. A., Makole, T. J., Nambatya, W., Esseku, Y., & Ashiru-Oredope, D. (2022). A scoping review of national antimicrobial stewardship activities in eight African countries and adaptable recommendations. Antibiotics, 11(9), 1149. doi: 10.3390/antibiotics11091149

34. Ayomide, I. T., Promise, L. O., Christopher, A. A., Okikiola, P. P., Esther, A. D., Favour, A. C., Agbo, O. S., Sandra, O., Chiagozie, O. J., Precious, A. C., & Ugonna, U. K. (2024). The impact of antimicrobial resistance on Co-INFECTIONS: Management strategies for HIV, TB and malaria. International Journal of Pathogen Research, 13(6), 117–128. doi: 10.9734/ijpr/2024/v13i6326

35. Prach, L. M., Treleaven, E., Isiguzo, C., & Liu, J. (2015). Care-seeking at patent and proprietary medicine vendors in Nigeria. BMC Health Services Research, 15(1). doi: 10.1186/s12913-015-0895-z

36. Palmer, G. H., & Buckley, G. J. (2021). Combating antimicrobial resistance and protecting the miracle of modern medicine. In National Academies Press eBooks.

37. Alhassan, J. A. K., & Abdallah, C. K. (2024). Health system interventions and responses to antimicrobial resistance: A scoping review of evidence from 15 African countries. PLOS Global Public Health, 4(9), e0003688. doi: 10.1371/journal.pgph.0003688

38. Mensah, N. K., Adzakpah, G., Kissi, J., Taylor-Abdulai, H., Johnson, S. B., Agbeshie, P. A., Opoku, C., Abakah, J., Osei, E., Agyekum, A. Y., & Boadu, R. O. (2024). Health Professionals' ethical, security, and patient safety concerns using Digital Health Technologies: A Mixed Method Research study. Health Services Insights, 17. doi: 10.1177/11786329241303379

39. Ilesanmi, O. S., & Afolabi, A. A. (2022). Sustainability of Donor-Funded Health-Related Programs Beyond the Funding Lifecycle in Africa: A Systematic review. Cureus. doi: 10.7759/cureus.24643

40. Ye, L., & Yang, H. (2020). From Digital Divide to Social Inclusion: A Tale of Mobile Platform Empowerment in Rural Areas. Sustainability, 12(6), 2424. doi: 10.3390/su12062424